Award recognizes MBF’s technological innovations and economic contributions
The U.S. Small Business Administration presented a prestigious Tibbetts Award to MBF Bioscience during a ceremony at the White House in Washington, D.C. on May 16th. The Tibbetts Award is presented annually to companies who are beacons of promise and models of excellence in high technology. The award recognizes MBF Bioscience for a number of accomplishments: technological innovation, serving federal Research and Development needs, encouraging diverse participation, and increasing the practical commercial use of federal research.
“We are very proud and thankful to be recognized by the Small Business Administration with a Tibbetts Award,” said Jack Glaser, President of MBF Bioscience. “Their SBIR program makes it possible for MBF Bioscience to develop innovative software for bioscience researchers. These researchers use our products extensively to make important discoveries about major health problems in society today such as Alzheimer’s, Parkinson’s, autism spectrum disorder, and traumatic brain injury; to name just a few.”
The Tibbetts Award is given to companies who participate in the Small Business Innovation Research (SBIR) program which is run by the U.S. Small Business Administration. The SBIR program is a highly competitive program that encourages small businesses to engage in Federal Research/Research and Development (R/R&D) that has the potential for commercialization.
MBF Bioscience has received SBIR awards to develop important technologies that are used in bioscience research. Those technologies include Neurolucida for analyzing neurons and brain mapping, Stereo Investigator for stereology and cell counting, and Biolucida Cloud for viewing and sharing 2D and 3D microscope images.